Heinke Conrad

594 total citations
16 papers, 460 citations indexed

About

Heinke Conrad is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Heinke Conrad has authored 16 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Heinke Conrad's work include Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (7 papers) and T-cell and B-cell Immunology (4 papers). Heinke Conrad is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (7 papers) and T-cell and B-cell Immunology (4 papers). Heinke Conrad collaborates with scholars based in Germany, United States and Netherlands. Heinke Conrad's co-authors include Helga Bernhard, Dirk H. Busch, Christian Peschel, Franz Hofmann, Norbert Klugbauer, Georg Bohn, Jörg Nährig, Falko Fend, Wolfgang Weber and Sven Moosmang and has published in prestigious journals such as Blood, The Journal of Immunology and FEBS Letters.

In The Last Decade

Heinke Conrad

15 papers receiving 453 citations

Peers

Heinke Conrad

ONCOL

IMMUN

CCM

GENET

Jenessa B. Smith United States

Roger Santimaria Switzerland

James J. Mulé United States

Rachel Rennard United States

Lorena Hernandez Spain

Jean-Loup Salzmann France

Jeanette Ampudia United States

Birgitta Clinchy Sweden

Eric Lynam United States

G. A. Luckenbach Germany

Jenessa B. Smith United States

Heinke Conrad

311 ×1.2

ONCOL

156 ×0.7

IMMUN

244 ×1.6

19 ×0.3

CCM

191 ×4.1

GENET

Citations per year, relative to Heinke Conrad Heinke Conrad (= 1×) peers Jenessa B. Smith

Countries citing papers authored by Heinke Conrad

Since Specialization

Citations

This map shows the geographic impact of Heinke Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinke Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinke Conrad more than expected).

Fields of papers citing papers by Heinke Conrad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heinke Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinke Conrad. The network helps show where Heinke Conrad may publish in the future.

Co-authorship network of co-authors of Heinke Conrad

This figure shows the co-authorship network connecting the top 25 collaborators of Heinke Conrad. A scholar is included among the top collaborators of Heinke Conrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinke Conrad. Heinke Conrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Speck, Tobias, Tillmann Michels, Antonio Sorrentino, et al.. (2015). A high‐throughput RNA i screen for detection of immune‐checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes. EMBO Molecular Medicine. 7(4). 450–463. 29 indexed citations

Ge, Yingzi, Felix J. Hartmann, Heinke Conrad, et al.. (2013). HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients. OncoImmunology. 2(6). e24962–e24962. 20 indexed citations

Witzens‐Harig, Mathias, Dirk Hose, Christina Pfirschke, et al.. (2013). Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6. Blood. 121(22). 4493–4503. 33 indexed citations

Sommermeyer, Daniel, et al.. (2012). NY‐ESO‐1 antigen‐reactive T cell receptors exhibit diverse therapeutic capability. International Journal of Cancer. 132(6). 1360–1367. 12 indexed citations

Krönig, Holger, Marcus Odendahl, Heinke Conrad, et al.. (2011). PD‐1 expression on Melan‐A‐reactive T cells increases during progression to metastatic disease. International Journal of Cancer. 130(10). 2327–2336. 30 indexed citations

Thiel, Uwe, Heinke Conrad, Dirk H. Busch, et al.. (2011). Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells. British Journal of Cancer. 104(6). 948–956. 29 indexed citations

Conrad, Heinke, J. Daniel, Holger Krönig, et al.. (2011). FLT3-regulated antigens as targets for leukemia-reactive cytotoxic T lymphocytes. Blood Cancer Journal. 1(3). e11–e11. 10 indexed citations

Conrad, Heinke, Lilian Stärck, Matthias Leisegang, et al.. (2010). Targeting the epidermal growth factor receptor (HER) family by T cell receptor gene-modified T lymphocytes. Journal of Molecular Medicine. 88(11). 1113–1121. 7 indexed citations

Witter, K., Heinke Conrad, H. Bernhard, Thomas Albert, & Teresa Kauke. (2009). HLA‐B*1832, a novel B allele was found through high‐resolution HLA typing of a Spanish blood donor. Tissue Antigens. 74(2). 170–172. 2 indexed citations

10.

Bonito, Paola Di, Felicia Grasso, Linda Petrone, et al.. (2009). Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein. Virology. 395(1). 45–55. 38 indexed citations

11.

Krönig, Holger, Heinke Conrad, Matthias Schiemann, et al.. (2009). Allorestricted T lymphocytes with a high avidity T‐cell receptor towards NY‐ESO‐1 have potent anti‐tumor activity. International Journal of Cancer. 125(3). 649–655. 25 indexed citations

12.

Conrad, Heinke, et al.. (2008). CTLs Directed against HER2 Specifically Cross-React with HER3 and HER4. The Journal of Immunology. 180(12). 8135–8145. 17 indexed citations

13.

Bernhard, Helga, Heinke Conrad, Jörg Nährig, et al.. (2007). Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer. Cancer Immunology Immunotherapy. 57(2). 271–280. 122 indexed citations

14.

Löhn, Matthias, Kirill Essin, Suk Ying Tsang, et al.. (2002). Cilnidipine is a novel slow-acting blocker of vascular L-type calcium channels that does not target protein kinase C. Journal of Hypertension. 20(5). 885–893. 15 indexed citations

15.

Bohn, Georg, Sven Moosmang, Heinke Conrad, et al.. (2000). Molecular basis of pacemaker current. 20.

16.

Bohn, Georg, Sven Moosmang, Heinke Conrad, et al.. (2000). Expression of T‐ and L‐type calcium channel mRNA in murine sinoatrial node. FEBS Letters. 481(1). 73–76. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact